Loxo Oncology Financial Statements Trends

LOXO -- USA Stock  

USD 155.75  1.84  1.17%

This module enables investors to look at Loxo Oncology various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Operating Expenses of 42.4 M, Preferred Dividends Income Statement Impact of 40 K or Research and Development Expense of 30.1 M, but also many exotic indicators such as Total Assets Per Share of 9.462, Quick Ratio of 60.303 or Net Current Assets as percentage of Total Assets of 115. This module is a perfect complement to use when analyzing Loxo Oncology Valuation or Volatility. It can also complement various Loxo Oncology Technical models. Please see also analysis of Loxo Oncology Correlation with competitors.

Loxo Oncology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets157.5 M157.5 M128.8 M
Increasing
Slightly volatile
Cash and Equivalents710.2 M68.2 M105.5 M
Increasing
Slightly volatile
Investments100.8 M85.7 M75.8 M
Increasing
Slightly volatile
Investments Current100.8 M85.7 M71.4 M
Increasing
Slightly volatile
Investments Non Current7.8 M6.6 M6.7 M
Increasing
Slightly volatile
Property Plant and Equipment Net103.5 K88 K38.6 K
Increasing
Slightly volatile
Trade and Non Trade Payables316.5 K269 K253 K
Increasing
Slightly volatile
Total Liabilities3.4 M2.9 M2.2 M
Increasing
Slightly volatile
Shareholders Equity181.9 M154.6 M128.9 M
Increasing
Slightly volatile
Accumulated Retained Earnings Deficit(78.6 M)(66.8 M)(43.9 M)
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income(18.8 K)(16 K)(24.2 K)
Increasing
Slightly volatile
Current Assets156.6 M156.6 M124.1 M
Increasing
Slightly volatile
Assets Non Current957.6 K814 K4.7 M
Decreasing
Slightly volatile
Current Liabilities2.9 M2.9 M2.1 M
Increasing
Slightly volatile
Shareholders Equity USD181.9 M154.6 M128.9 M
Increasing
Slightly volatile
Cash and Equivalents USD80.2 M68.2 M53 M
Increasing
Slightly volatile

Loxo Oncology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General and Administrative Expense12.4 M10.5 M7.8 M
Increasing
Slightly volatile
Research and Development Expense30.1 M25.6 M18.6 M
Increasing
Slightly volatile
Operating Expenses42.4 M36.1 M26.3 M
Increasing
Slightly volatile
Consolidated Income(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Net Income(127.9 M)(35.9 M)(33.4 M)
Decreasing
Slightly volatile
Preferred Dividends Income Statement Impact40 K34 K34.5 K
Increasing
Slightly volatile
Net Income Common Stock(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Weighted Average Shares30.1 M16.9 M11.2 M
Increasing
Slightly volatile
Weighted Average Shares Diluted19.9 M16.9 M10.4 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Net Income Common Stock USD(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Earning Before Interest and Taxes USD(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Operating Income(42.4 M)(36.1 M)(26.3 M)
Decreasing
Slightly volatile

Loxo Oncology Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(109.4 K)(93 K)(41.7 K)
Decreasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(20.1 M)(17.1 M)(52 M)
Increasing
Slightly volatile
Net Cash Flow from Financing84.2 M71.6 M102.1 M
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares84.2 M71.6 M74.5 M
Increasing
Stable
Net Cash Flow from Investing(20.2 M)(17.2 M)(52 M)
Increasing
Slightly volatile
Net Cash Flow from Operations244.2 M(30.2 M)1 M
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents28.5 M24.2 M27.7 M
Decreasing
Slightly volatile
Share Based Compensation7.2 M6.2 M4.2 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion20 K17 K6.6 K
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(2.4941)(2.12)(2.7778)
Increasing
Slightly volatile
Earnings per Diluted Share(4.39)(2.12)(2.9358)
Increasing
Very volatile
Earnings per Basic Share USD(2.4941)(2.12)(2.7778)
Increasing
Slightly volatile
Return on Average Equity(0.4104)(0.314)(0.382)
Increasing
Slightly volatile
Return on Average Assets(0.1669)(0.308)(0.3042)
Increasing
Slightly volatile
Return on Invested Capital(0.6012)(0.511)(0.5812)
Increasing
Slightly volatile
Enterprise Value over EBITDA(14.4471)(12.28)(6.7519)
Decreasing
Slightly volatile
Enterprise Value over EBIT(14.1176)(12.0)(6.1765)
Decreasing
Slightly volatile
Price to Earnings Ratio(20.33)(13.42)(7.6092)
Decreasing
Slightly volatile
Price to Book Value12.463.0712.9628
Increasing
Slightly volatile
Debt to Equity Ratio0.0180.0180.0167
Increasing
Slightly volatile
Current Ratio3.5254.90554.2269
Decreasing
Slightly volatile
Free Cash Flow per Share23.61(1.792)(0.2232)
Increasing
Slightly volatile
Book Value per Share10.10358.58814.0783
Decreasing
Slightly volatile
Tangible Assets Book Value per Share10.29068.74714.3096
Decreasing
Slightly volatile
Total Assets Per Share9.4628.042722.721
Decreasing
Slightly volatile
Cash Flow Per Share(1.8137)(1.5417)(4.2239)
Increasing
Slightly volatile
Quick Ratio60.30351.257554.6379
Decreasing
Stable
Net Current Assets as percentage of Total Assets11597.671198.4086
Increasing
Slightly volatile

Loxo Oncology Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(133 M)(35.9 M)(33.8 M)
Decreasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD(42.2 M)(35.9 M)(26.3 M)
Decreasing
Slightly volatile
Market Capitalization4.8 B474.8 M648.2 M
Increasing
Slightly volatile
Enterprise Value4.5 B440.3 M538 M
Increasing
Slightly volatile
Invested Capital106.8 M116.5 M41.5 M
Increasing
Slightly volatile
Average Equity134.6 M114.4 M74 M
Increasing
Slightly volatile
Average Assets137.2 M116.6 M83.7 M
Increasing
Slightly volatile
Invested Capital Average82.7 M70.3 M47.2 M
Increasing
Slightly volatile
Tangible Asset Value185.2 M157.5 M131.1 M
Increasing
Slightly volatile
Free Cash Flow(35.6 M)(30.3 M)(22.3 M)
Decreasing
Slightly volatile
Working Capital153.8 M153.8 M121.9 M
Increasing
Slightly volatile
Net Income Per Employee(2.5 M)(2.1 M)(1.6 M)
Decreasing
Slightly volatile

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Loxo Oncology Fundamental Drivers

Loxo Oncology Fundamental Market Drivers

Forward Price Earnings-33.19
Short Percent Of Float11.07%
Average Daily Volume Last 10 Day318.74k
Shares Short Prior Month2.99M
Average Daily Volume In Three Month568.25k
Date Short InterestJuly 13, 2018
Fifty Day Average173.63
Two Hundred Day Average142.45

Loxo Oncology Upcoming Events

Loxo Oncology Upcoming Company Events

Upcoming Quarterly ReportMarch 21, 2017
Next Earnings ReportMay 3, 2017
Please see also analysis of Loxo Oncology Correlation with competitors. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com